Weight Management

In a clinical trial, 86.4% of patients on semaglutide achieved a 5% weight loss at week 68 compared to 31.5% with placebo.

Estosterone undecanoate (Tlando; Antares Pharma, Inc) is indicated as testosterone replacement therapy for conditions associated with a deficiency or absence of endogenous testosterone in adult patients.

Semaglutide (Ozempic; Novo Nordisk) approved as a once-weekly subcutaneous injection for the treatment of adults with type 2 diabetes.

Basaglar is indicated to improve glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes.

Empagliflozin and linagliptin (Glyxambi) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Results of studies show that women with obesity who get these weight loss procedures often also have preventative benefits.

Ozempic is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Increasing physical activities and reducing caloric intake isn’t always enough to conquer obesity.

New study results show that rapidly adding pounds in the first and final months of gestation likely plays a key role in the development of excess fat tissue in female children and adolescents.

Even after taking cardiovascular risks or vascular brain injury into account, the association remained, study results show.

Limited empirical data from new study suggests correlations between obesity and individual SDOH, such as education level, food environment, income, and neighborhood.

Investigators found that an additional hour of sleep correlated with a 26% decrease in an infant’s risk of being overweight.

Pharmacists can help to reduce the prevalence of food insecurity and its negative health care outcomes by tailoring clinical care to each individual patient’s needs.

Marinol is a cannabinoid indicated for anorexia associated with weight loss in patients with AIDS.

Obesity, high blood pressure, and diabetes were the most common comorbidities.

An embryonic stem cell model allowed investigators to study the genetic architecture first in hypothalamic progenitor cells, prior to their full development, and then nucleus-like hypothalamic neurons.

Almost 80% of individuals with type 2 diabetes lost more than 22 pounds and maintained that weight loss in remission for at least 2 years, study results show.

Individuals treated with Wegovy who are obese are overweight are more likely to lose at least 5% of their body weight compared with the placebo.

This weight loss can prevent the onset of type 2 diabetes for new mothers.

They are attempting to determine the associations and connections to further benefit individuals using the therapies.

Dumping syndrome occurs when food, especially sugar, moves from the stomach into the small bowel too quickly.

Having community pharmacists to influence outcomes associated with social determinants of health in the US population is vital to improving overall patient outcomes.

Patients with bulimia may use different methods to get rid of calories and prevent weight gain, such as self-inducing vomiting on a regular basis.

Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor.

The researchers also demonstrated that ketone supplements may be a novel therapy for protecting and improving brain health in people with obesity who are at risk of developing neurocognitive impairment.